BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3979587)

  • 1. Titrating the dose of bromocriptine when treating hyperprolactinemic infertile women.
    Soto-Albors CE; Daly DC; Walters CA; Ying YK; Riddick DH
    Fertil Steril; 1985 Mar; 43(3):485-7. PubMed ID: 3979587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A; Crespo G; Coria I; Espinosa de los Monteros A
    Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine in the treatment of hyperolactinemic amenorrhea.
    Badano AR; Miechi HR; Mirkin A; Arcángeli OA; Aparicio NJ; Rodríguez A; Oliva A; Turner D; Figueroa Casas PR
    Fertil Steril; 1979 Feb; 31(2):124-9. PubMed ID: 570131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
    Rasmussen C; Bergh T; Nillius SJ; Wide L
    Fertil Steril; 1985 Jul; 44(1):31-4. PubMed ID: 4007192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of treatment with bromoergocryptine in functional infertility caused by corpus luteum insufficiency].
    Apró G; Godó G; Sas M
    Zentralbl Gynakol; 1983; 105(8):473-7. PubMed ID: 6868875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine treatment of hyperprolactinemic infertility with ovulatory disturbances.
    Borenstein R; Katz Z; Lancet M; Caspi B; Ben-David M
    Int J Gynaecol Obstet; 1980; 18(3):195-9. PubMed ID: 6109654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in serum prolactin during bromocriptine-induced pregnancy and subsequent restoration of reproductive function in some hyperprolactinemic women.
    Seki K; Kato K
    Endocrinol Jpn; 1987 Oct; 34(5):701-7. PubMed ID: 3436300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin concentrations in ovulatory but infertile women: treatment with bromocriptine.
    Lenton EA; Sobowale OS; Cooke ID
    Br Med J; 1977 Nov; 2(6096):1179-81. PubMed ID: 589073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
    Kletzky OA; Vermesh M
    Fertil Steril; 1989 Feb; 51(2):269-72. PubMed ID: 2912773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone patterns during bromocriptine-induced pregnancy in hyperprolactinemic patients.
    Belforte L; Bruno M; Campagnoli C; Fessia L; Massara F; Molinatti GM
    Eur J Obstet Gynecol Reprod Biol; 1980 Jun; 10(5):309-17. PubMed ID: 7190514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hyperprolactinemia in infertile women.
    Asukai K; Uemura T; Minaguchi H
    Fertil Steril; 1993 Sep; 60(3):423-7. PubMed ID: 8375520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
    Fukunaga T
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea.
    DeVane GW; Guzick DS
    Fertil Steril; 1986 Dec; 46(6):1026-31. PubMed ID: 3781021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy in hyperprolactinemic infertile women treated with vaginal bromocriptine: report of two cases and review of the literature.
    Ricci G; Giolo E; Nucera G; Pozzobon C; De Seta F; Guaschino S
    Gynecol Obstet Invest; 2001; 51(4):266-70. PubMed ID: 11408739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and outcome of thirty-five pregnancies in infertile hyperprolactinemic women.
    Skrabanek P; McDonald D; Meagher D; de Valera E; Carroll C; Lanigan O; Powell D
    Fertil Steril; 1980 Apr; 33(4):391-5. PubMed ID: 7364069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of bromocriptine-induced pregnancy and delivery on infertile cases with pituitary microadenoma].
    Aso T; Motohashi T; Takahashi A; Su JH; Matsuoka M; Horie K; Tojo S
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):459-68. PubMed ID: 6854094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.